🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11,276 results for “Te” Clear

  1. Efgartigimod, Placebo for efgartigimod

    argenx

    Thyroid Eye Disease (TED)

    phase 3 small molecule active

    1 trial

  2. Efluelda Injektionssuspension in einer Fertigspritze Trivalenter Influenza-Spaltimpfstoff (inaktiviert), 60 Mikrogramm HA/Stamm, Influvac, suspensie voor injectie 0,5 ml (influenza vaccin, oppervlakte antigeen, geïnactiveerd)., Trivalent Influenza Vaccine - High Dose (TIV-HD)

    Abbott Laboratories

    Influenza immunisation

    phase 3 small molecule active

    1 trial

  3. Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    phase 3 mab completed

    1 trial

  4. Elaprase 2 mg/ml concentrate for solution for infusion

    Denali Therapeutics

    Mucopolysaccharidosis Type II [MPS II]

    phase 3 small molecule active

    1 trial

  5. Elenestinib

    Blueprint Medicines (Netherlands) B.V.

    Indolent Systemic Mastocytosis

    phase 3 small molecule active

    1 trial

  6. Eligard 22,5 mg poeder en oplosmiddel voor oplossing voor injectie

    Disc Medicine

    Patients with biochemical recurrence after primary treatment of prostate cancer presenting with =<4 metastases

    phase 3 small molecule active

    1 trial

  7. Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat, Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat

    Genzyme Europe B.V.

    Gaucher's disease type I; Gaucher's disease type III

    phase 3 small molecule active

    1 trial

  8. Eliquis 5 mg film-coated tablets, ACETYLSALICYLIC ACID

    Pari Pharma GmbH

    Aortic bioprothesis implanted patient for valvular heart disease

    phase 3 small molecule active

    1 trial

  9. Elritercept

    Takeda

    Myelodysplastic Syndrome

    phase 3 small molecule active

    1 trial

  10. Eltrombopag

    GlaxoSmithKline

    Non-alcoholic Steatohepatitis

    phase 3 small molecule terminated

    1 trial

  11. Eltrombopag 25 MG Oral Tablet

    The First People's Hospital of Lianyungang

    Stem Cell Transplant Complications

    phase 3 small molecule completed

    1 trial

  12. Empagliflozin 10 MG

    COLLEGIUM PHARMACEUTICAL, INC

    Acute Decompensated Heart Failure

    phase 3 small molecule active

    1 trial

  13. Empagliflozin 10 mg

    United Therapeutics Europe Ltd

    Acute Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  14. Empliciti 400 mg powder for concentrate for solution for infusion., DARZALEX 1800 mg solution for injection, Alnuctamab, Imnovid 2 mg hard capsules, Alnuctamab, Imnovid 3 mg hard capsules, Imnovid 1 mg hard capsules, Kyprolis 60 mg powder for solution for infusion, Fortecortin® Inject 8 mg Injektionslösung in einer Ampulle, DEXAMETHASONE, Imnovid 4 mg hard capsules

    Celgene Europe Limited

    Relapsed and/or Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  15. Enbrel 50 mg solution for injection in pre-filled syringe, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Guselkumab 1 mL PFS Placebo, Guselkumab, Guselkumab 0.5 mL Varioject Placebo, Enbrel 25 mg powder and solvent for solution for injection

    Janssen-Cilag International N.V.

    Chronic Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  16. Endoscopic submucosal dissection

    United Therapeutics Europe Ltd

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  17. Endoxifen, Identical placebo tablets of Endoxifen manufactured by Intas Pharmaceuticals Limited, India. The placebo tablets were manufactured using the same excipients and the manufacturing process of endoxifen tablets. Like endoxifen 8 mg tablets, the placebo tablets are green coloured, round shape, biconvex, enteric coated tablets plain on both sides. The placebo for Endoxifen Tablets 8 mg was manufactured following the same procedure as the drug product without using endoxifen citrate.

    Lacuna Pharma Pty Ltd

    Bipolar I Disorder

    phase 3 small molecule active

    1 trial

  18. Enhanced standard management

    United Therapeutics Europe Ltd

    Pacemaker Complication

    phase 3 other active

    1 trial

  19. Enoxaparin sodium (XRP4563)

    Sanofi Pasteur

    Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  20. Entecavir

    Bristol-Myers Squibb

    Hepatitis B, Chronic

    phase 3 small molecule completed

    1 trial

  21. Entecavir

    Hoffmann-La Roche

    Pediatric Immuno-Tolerant Chronic Hepatitis B

    phase 3 small molecule completed

    1 trial

  22. Entyvio 108 mg solution for injection in pre-filled syringe, Entyvio 300 mg powder for concentrate for solution for infusion

    Takeda

    Active Ulcerative Colitis or Crohn’s Disease

    phase 3 small molecule active

    1 trial

  23. Enzalutamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Hormone Sensitive Prostate Cancer

    phase 3 small molecule active

    1 trial

  24. Epcoritamab (GEN3013), Revlimid 5 mg hard capsules, Revlimid 20 mg hard capsules, Epcoritamab (GEN3013), Truxima 500 mg concentrate for solution for infusion, Truxima 100 mg concentrate for solution for infusion

    AbbVie Deutschland GmbH & Co. KG

    Relapsed and Refractory Follicular Lymphoma

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources